Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis

[1]  D. Plas,et al.  Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition. , 2011, Cancer research.

[2]  J. Rathmell,et al.  Cell metabolism: an essential link between cell growth and apoptosis. , 2011, Biochimica et biophysica acta.

[3]  A. Caro-Maldonado,et al.  Sugar-free approaches to cancer cell killing , 2011, Oncogene.

[4]  W. Tse,et al.  Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin , 2010, Leukemia.

[5]  A. Gartel,et al.  Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells , 2010, Leukemia.

[6]  P. Auberger,et al.  Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation , 2010, Oncogene.

[7]  D. Green,et al.  The BCL-2 family reunion. , 2010, Molecular cell.

[8]  Erinna F. Lee,et al.  The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia , 2009, Leukemia.

[9]  M. Warr,et al.  Unique biology of Mcl-1: therapeutic opportunities in cancer. , 2008, Current molecular medicine.

[10]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[11]  P. Auberger,et al.  Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis , 2004, Oncogene.

[12]  A. W. Harris,et al.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells , 1988, The Journal of experimental medicine.